PANZYGA

Manufacturer:

Pfizer

Name:

PANZYGA

HCPCS Code Descriptor:

Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg

Category:

J Code

HCPCS:

J1599

NDC(s):

00069-1011-02, 68982-0822-01, 68982-0822-05, 68982-0822-06, 68982-0822-04, 68982-0822-03, 68982-0822-02

Primary Type:

Immunoglobulin

Generic Status:

Multi-Source

Route of Administration:

Intravenous

About:

PANZYGA is an Immunoglobulin drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J1599 is aligned to the drug PANZYGA.

Panzyga is a medication that boosts the patient's natural immune system. Panzyga is made with healthy human blood that contains a high level of antibodies, these antibodies act to boost the patient’s immune system. Panzyga can be used to treat a variety of disorders including certain muscle weakness disorders, nerve disorders, and blood vessel disorders. Panzyga is dual manufactured by Pfizer and Octapharma USA.